We previously described the discovery of 1,2 oxazines as anti-cancer drugs [32], along with their roles in triggering apoptosis, significantly increasing the population of sub-G1 cells and inhibiting the capacity of NF–κB to bind DNA in HCC cells. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.